The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

allegrodx.com

Total Raised

$9.92M

Investors Count

8

Deal Terms

3

Allegro Diagnostics Funding, Allegro Diagnostics Valuation & Allegro Diagnostics Revenue

5 Fundings

Allegro Diagnostics's latest funding round was a Acquired for on September 5, 2014.

Allegro Diagnostics's valuation in July 2011 was $13.3M.

Allegro Diagnostics's latest post-money valuation is from September 2014.

Sign up for a free trial to see Allegro Diagnostics's valuations in September 2014, February 2008 and more.

Date

Round

Amount

Investors

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Revenue

Sources

9/5/2014

Acquired

$99M

0

FY undefined

1

7/7/2011

Series A - II

$99M

$13.3M

0

FY undefined

10

11/25/2009

Grant - II

$99M

0

FY undefined

0

10/21/2009

Grant

$99M

0

FY undefined

0

2/18/2008

Series A

$99M

$99M

0

FY undefined

0

Date

9/5/2014

7/7/2011

11/25/2009

10/21/2009

2/18/2008

Round

Acquired

Series A - II

Grant - II

Grant

Series A

Amount

$99M

$99M

$99M

$99M

Investors

Valuation

$99M

$13.3M

$99M

Revenue

0

FY undefined

0

FY undefined

0

FY undefined

0

FY undefined

0

FY undefined

Sources

1

10

0

0

0

Allegro Diagnostics Deal Terms

3 Deal Terms

Allegro Diagnostics's deal structure is available for 3 funding rounds, including their Acquired from September 05, 2014.

Round

Acquired

Series A - II

Series A

Funding Date

$99M

$99M

$99M

Pre-Money Valuation

$99M

Post-Money Valuation

$99M

$99M

Amount Raised

$99M

$99M

Shares Authorized

Issuance Price

$99M

Dividend Rate

$99M

Liquidation Preferences

$99M

Liquidation Price

Participation

Conversion Price

Anti Dilution

$99M

General Voting

$99M

$99M

$99M

Board Voting

$99M

$99M

$99M

Par Value

Round

Funding Date

Pre-Money Valuation

Post-Money Valuation

Amount Raised

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

Board Voting

Par Value

Acquired

$99M

$99M

$99M

$99M

Series A - II

$99M

$99M

$99M

$99M

$99M

$99M

$99M

$99M

$99M

$99M

Series A

$99M

$99M

$99M

$99M

Allegro Diagnostics Investors

8 Investors

Allegro Diagnostics has 8 investors. Veracyte invested in Allegro Diagnostics's Acquired funding round.

First funding

Last Funding

Investor

Rounds

Board Seats

Type

Location

9/5/2014

9/5/2014

1
Acquired

Corporation

California

00/00/0000

00/00/0000

Catalyst Health Ventures

Subscribe to see more

Venture Capital

Massachusetts

00/00/0000

00/00/0000

Kodiak Venture Partners

Subscribe to see more

Venture Capital

Massachusetts

00/00/0000

00/00/0000

Qualifying Therapeutic Discovery Project

Subscribe to see more

Government

DC

00/00/0000

00/00/0000

Small Business Innovation Research Awards

Subscribe to see more

Government

DC

First funding

9/5/2014

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Last Funding

9/5/2014

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Investor

Catalyst Health Ventures

Kodiak Venture Partners

Qualifying Therapeutic Discovery Project

Small Business Innovation Research Awards

Rounds

1
Acquired

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Board Seats

Type

Corporation

Venture Capital

Venture Capital

Government

Government

Location

California

Massachusetts

Massachusetts

DC

DC

You May Also Like

A
AngioLogix

AngioLogix is a provider of cardiovascular health diagnostics.

D
Dilon Technologies

Dilon Technologies delivers clinically useful imaging and intra operative systems appropriate for early disease diagnosis and surgical applications. Dilon's cornerstone product, the Dilon Molecular Breast Imaging System, is a high-resolution, compact camera, and is available as a single or dual head camera. The Dilon cameras have been optimized to perform Molecular Breast Imaging (MBI/BSGI) procedure that aids in early detection of breast cancer.

N
Nanogen Adavanced Diagnostics S.r.l.

At Nanogen, Inc., the company develop diagnostic products that enable physicians to deliver improved patient care. The company's products allow faster and easier diagnosis, treatment and monitoring of cardiovascular disease and infectious diseases. These products include molecular diagnostic kits and reagents, and rapid test kits, which can be used in urgent care settings or at the point-of-care. Nanogen has pioneered developments in areas involving biomarkers, molecular biology and nanotechnology. The company's business focus is to bring better results to diagnostics and healthcare.

P
ProteoGenix

ProteoGenix offers maternal-fetal diagnostics

H
Hx Diagnostics

Hx Diagnostics offers rapid diagnostics for seasonal and emerging infectious diseases.

Akonni Biosystems Logo
Akonni Biosystems

Akonni Biosystems is a molecular diagnostics (MDx) company that develops, manufactures, and markets integrated molecular diagnostic systems.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.